William T. Symonds
Altair Engineering (United States)(US)
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, HIV/AIDS drug development and treatment, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection(2013)1,776 cited
- → Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection(2014)1,699 cited
- → Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection(2014)1,302 cited
- → Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection(2014)1,191 cited
- → Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis(2014)1,121 cited
- → Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options(2013)1,079 cited
- → Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study(2014)814 cited
- → Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3(2014)796 cited
- → Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C(2013)754 cited
- → Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial(2013)547 cited